The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,4-Dichloro-phenyl)-3-(4-methoxy-phenyl)-4-morpholin-4-yl-pyrrole-2,5-dione ID: ALA2316726
Cas Number: 1417162-36-7
PubChem CID: 71547138
Max Phase: Preclinical
Molecular Formula: C21H18Cl2N2O4
Molecular Weight: 433.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(C2=C(N3CCOCC3)C(=O)N(c3ccc(Cl)c(Cl)c3)C2=O)cc1
Standard InChI: InChI=1S/C21H18Cl2N2O4/c1-28-15-5-2-13(3-6-15)18-19(24-8-10-29-11-9-24)21(27)25(20(18)26)14-4-7-16(22)17(23)12-14/h2-7,12H,8-11H2,1H3
Standard InChI Key: JMPJNNOSVCHYOU-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.4363 -1.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4352 -2.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 -3.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8666 -2.7855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8637 -1.9549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1482 -1.5457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1485 -4.0229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4809 -4.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7357 -5.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5607 -5.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8158 -4.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6006 -4.2532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6962 -4.2526 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1458 -0.7206 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.5767 -1.5396 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.9919 -5.9949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5963 -6.7202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0266 -7.4233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8523 -7.4022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2459 -6.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8133 -5.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3193 -6.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4932 -5.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0760 -6.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4839 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3132 -7.4278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7267 -6.7162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0676 -8.1374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2425 -8.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 1 0
3 7 1 0
11 12 2 0
8 13 2 0
6 14 1 0
5 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 16 1 0
10 16 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
9 22 1 0
25 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.29Molecular Weight (Monoisotopic): 432.0644AlogP: 3.62#Rotatable Bonds: 4Polar Surface Area: 59.08Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.81CX LogP: 3.41CX LogD: 3.41Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -1.14
References 1. Budke B, Kalin JH, Pawlowski M, Zelivianskaia AS, Wu M, Kozikowski AP, Connell PP.. (2013) An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity., 56 (1): [PMID:23231413 ] [10.1021/jm301565b ] 2. Huang F, Mazin AV.. (2014) Targeting the homologous recombination pathway by small molecule modulators., 24 (14): [PMID:24856061 ] [10.1016/j.bmcl.2014.04.088 ]